Serge Livio Ferrari

35PUBLICATIONS
126CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Computational modelling and simulation in earth sciencesBiomechanicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jun 28, 2026
Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates.

|Apr 25, 2026
Precision and age-related changes of 3D-DXA reconstructions and FEA of the proximal femur in comparison to DXA.

|Mar 30, 2026
A simple personalised prediction model for hip fracture risk based on mechanistic parameters.

Christina Wapp, Yvan Gugler, Paula Cameron

|Mar 25, 2026
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase.

Serge Ferrari, Lothar Seefried, Dénes Páll

|Mar 17, 2026
Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in Osteoporosis.

Serge Ferrari, Cyril Thouverey, Maude Gerbaix

Pageof 6